July 05, 2009 06:00 PM Eastern Time
BUSINESS WIRE
Alcon Commences Phase 2 Clinical Trial of NovaBay’s NVC-422 for Viral Conjunctivitis
Tweet
View Full Size
Download
Thumbnail
GIF
,
120
x
30
,
1.6 KB
Preview
JPEG
,
144
x
36
,
2.0 KB
Small
JPEG
,
227
x
57
,
2.5 KB
Full Size
JPEG
,
227
x
57
,
7.6 KB
Smart Multimedia Gallery
View and Share Graphic
Download Small
Download Full Size
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
All News
|
News with Multimedia
>
News Release: Alcon Commences Phase 2 Clinical Trial of NovaB...
Get Business Wire News on Your Website
Terms of Use
|
©2012 Business Wire
Better Be Business Wired.
Business Wire
is the leading source for
press releases
, photos, multimedia and
regulatory filings
from companies and groups throughout the world.